165 related articles for article (PubMed ID: 19647612)
1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale.
Shen P; Stewart JH; Levine EA
Curr Probl Cancer; 2009; 33(3):125-41. PubMed ID: 19647612
[No Abstract] [Full Text] [Related]
2. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer with peritoneal surface disease.
Shen P; Stewart JH; Levine EA
Curr Probl Cancer; 2009; 33(3):154-67. PubMed ID: 19647614
[No Abstract] [Full Text] [Related]
3. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications.
Shen P; Stewart JH; Levine EA
Curr Probl Cancer; 2009; 33(3):168-93. PubMed ID: 19647615
[No Abstract] [Full Text] [Related]
4. Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Rothfield KP; Crowley K
Surg Oncol Clin N Am; 2012 Oct; 21(4):533-41. PubMed ID: 23021714
[TBL] [Abstract][Full Text] [Related]
5. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
Piso P; Glockzin G; von Breitenbuch P; Popp FC; Dahlke MH; Schlitt HJ; Nissan A
J Surg Oncol; 2009 Sep; 100(4):317-20. PubMed ID: 19697438
[TBL] [Abstract][Full Text] [Related]
6. Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Moradi BN; Esquivel J
J Surg Oncol; 2009 Sep; 100(4):293-6. PubMed ID: 19697425
[TBL] [Abstract][Full Text] [Related]
7. [Hyperthermic intraperitoneal chemotherapy].
Leebmann H; Piso P
Chirurg; 2019 Jul; 90(7):593-604. PubMed ID: 31190081
[TBL] [Abstract][Full Text] [Related]
8. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
[TBL] [Abstract][Full Text] [Related]
9. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
Kusamura S; Dominique E; Baratti D; Younan R; Deraco M
J Surg Oncol; 2008 Sep; 98(4):247-52. PubMed ID: 18726886
[TBL] [Abstract][Full Text] [Related]
10. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma with peritoneal metastasis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
Bhagwandin SB; Salti GI
Tumori; 2015 Mar; 101(1):e1-3. PubMed ID: 25702649
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients.
Msika S; Gruden E; Sarnacki S; Orbach D; Philippe-Chomette P; Castel B; Sabaté JM; Flamant Y; Kianmanesh R
J Pediatr Surg; 2010 Aug; 45(8):1617-21. PubMed ID: 20713209
[TBL] [Abstract][Full Text] [Related]
13. Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results.
Roviello F; Roviello G; Petrioli R; Marrelli D
Crit Rev Oncol Hematol; 2015 Sep; 95(3):297-305. PubMed ID: 25900072
[TBL] [Abstract][Full Text] [Related]
14. [Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].
Mátrai Z; Péley G; Kovács T; Rényi VF; Szívós E; Szabó E; Vereczkey I; Török K; Köves I
Orv Hetil; 2006 Jan; 147(4):147-58. PubMed ID: 16515023
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: initial experience in Oaxaca, Mexico.
García-Matus R; Hernández-Hernández CA; Leyva-García O; Vásquez-Ciriaco S; Flores-Ayala G; Navarro-Hernández Q; Pérez-Bustamante G; Valencia-Mijares NM; Esquivel J
Am Surg; 2012 Sep; 78(9):942-6. PubMed ID: 22964201
[TBL] [Abstract][Full Text] [Related]
16. American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer.
Esquivel J; Piso P; Verwaal V; Bachleitner-Hofmann T; Glehen O; González-Moreno S; Deraco M; Pelz J; Alexander R; Glockzin G
J Surg Oncol; 2014 Dec; 110(7):777-8. PubMed ID: 25043759
[No Abstract] [Full Text] [Related]
17. Reported impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
Sugarbaker PH
Ann Surg Oncol; 2008 Jun; 15(6):1800-1; author reply 1802-3. PubMed ID: 18196342
[No Abstract] [Full Text] [Related]
18. [Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy].
Glockzin G; Ghali N; Lang SA; Agha A; Schlitt HJ; Piso P
Chirurg; 2007 Dec; 78(12):1100, 1102-6, 1108-10. PubMed ID: 17992490
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Roviello F; Caruso S; Marrelli D; Pedrazzani C; Neri A; De Stefano A; Pinto E
G Chir; 2011 Apr; 32(4):211-33. PubMed ID: 21554854
[TBL] [Abstract][Full Text] [Related]
20. Reply to "The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery".
Macrì A; Fleres F; Cucinotta E; Catanoso R; Saladino E
Ren Fail; 2015 Mar; 37(2):357. PubMed ID: 25418058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
